<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03001284</url>
  </required_header>
  <id_info>
    <org_study_id>UMFCD-141531-RM</org_study_id>
    <nct_id>NCT03001284</nct_id>
  </id_info>
  <brief_title>Multiple Sclerosis Produces Cardiovascular Subclinical Dysfunction</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Carol Davila University of Medicine and Pharmacy</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Carol Davila University of Medicine and Pharmacy</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Multiple sclerosis (MS), debilitating disease involving primarily the central nervous system,&#xD;
      may cause cardiovascular dysfunction, due to autonomous nervous system dysfunction, physical&#xD;
      invalidity, increased oxidative stress, and systemic inflammatory status, but the detailed&#xD;
      mechanisms are not elucidated. The investigators aimed to assess left and right ventricular&#xD;
      (LV and RV) function, left atrial (LA) function, arterial function, and&#xD;
      atrial-ventricular-arterial coupling in patients with MS, compared to control subjects. LV&#xD;
      systolic and diastolic function and RV function were assessed by 2D- and 3D-&#xD;
      echocardiography, tissue Doppler, and speckle tracking echocardiography. LA function was&#xD;
      assessed by LA volume index and LA strain. Arterial remodeling and stiffness were assessed by&#xD;
      intima media-thickness, pulse wave velocity, and parameters of wave intensity and endothelial&#xD;
      function&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>October 2012</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Left ventricle systolic dysfunction - by echocardiography</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Right ventricle systolic dysfunction- by echocardiography</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Left ventricular diastolic function - by echocardiography</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>arterial function - by vascular echography</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">103</enrollment>
  <condition>Multiple Sclerosis</condition>
  <arm_group>
    <arm_group_label>Multiple sclerosis patients</arm_group_label>
    <description>patients with confirmed multiple sclerosis, diagnosed according to the revised McDonald's criteria</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control subjects</arm_group_label>
    <description>control subjects, matched for age, gender, and presence of cardiovascular risk factors</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>NO intervention</intervention_name>
    <arm_group_label>Control subjects</arm_group_label>
    <arm_group_label>Multiple sclerosis patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        te investigators enrolled prospectively patients with confirmed multiple sclerosis,&#xD;
        diagnosed according to the revised McDonald's criteria[8], and control subjects, matched&#xD;
        for age, gender, and presence of cardiovascular risk factors.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. age between 18 and 65 years;&#xD;
&#xD;
          2. patients with confirmed MS diagnosis, both newly diagnosed or already under&#xD;
             immunomodulatory treatment;&#xD;
&#xD;
          3. informed consent signed.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. MS treated with mitoxantrone;&#xD;
&#xD;
          2. patients with known cardiovascular disease;&#xD;
&#xD;
          3. presence of other neurological conditions;&#xD;
&#xD;
          4. any renal, pulmonary, hepatic or hematological disease;&#xD;
&#xD;
          5. diabetes mellitus;&#xD;
&#xD;
          6. any degree of arterial hypertension;&#xD;
&#xD;
          7. pregnancy;&#xD;
&#xD;
          8. and difficult acoustic window&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>December 2016</verification_date>
  <study_first_submitted>December 8, 2016</study_first_submitted>
  <study_first_submitted_qc>December 20, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 23, 2016</study_first_posted>
  <last_update_submitted>December 20, 2016</last_update_submitted>
  <last_update_submitted_qc>December 20, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 23, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Carol Davila University of Medicine and Pharmacy</investigator_affiliation>
    <investigator_full_name>Raluca Mincu</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Multiple Sclerosis</mesh_term>
    <mesh_term>Sclerosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

